Skin Booster can help address issues such as dry skin and reduced elasticity... What should you keep in mind?
SculpSure/Sculpa, Jryn, Macrogen, Juveline, collagen—these are all skincare products designed to address skin dryness and loss of elasticity. What should you keep in mind when choosing them? The cold winds of winter can leave skin dry and sensitive. Due to seasonal changes and large temperature differences between indoors and outdoors, the skin’s barrier is weakened, making signs of aging such as fine lines more noticeable. However, relying solely on cosmetics to improve existing fine lines, reduced skin elasticity, or dryness doesn’t yield very satisfactory results. If you notice your skin problems worsening ahead of year-end gatherings, social events with friends or family, or other similar occasions, it’s time to consider treatments like SculpSure/Sculpa. These treatments work by delivering active ingredients directly into the dermis to promote collagen production and enhance the skin’s regenerative capacity. For example, Macrogen uses PN components extracted from salmon DNA, which effectively addresses skin dryness, abnormal keratinization, fine lines, and boosts skin elasticity while also helping to restore skin health and soothe it. Macrogen Repairer, on the other hand, utilizes C-PDRN combined with amino acids and hyaluronic acid to repair damaged skin. Compared to traditional Macrogen, its PN molecules are smaller, resulting in higher absorption rates and stronger moisture retention, while also reducing side effects like pain, redness, and irritation. The key to these treatments lies in using microneedles to gently deliver the active ingredients of Macrogen or Macrogen Repairer deep into the skin, ensuring even absorption and sustained effectiveness. Therefore, when selecting such products, not only should you consider the price, but the skill level of the practitioner is equally important. Another product, Juveline, is a collagen supplement made by combining high-molecular PLA with hyaluronic acid. Its advantage lies in its ability to stimulate the skin to produce its own collagen, thereby improving areas where the natural firmness has declined or fine lines are prominent. Juveline is ideal for areas requiring targeted care such as sagging eyelids, fine lines around the eyes and mouth, helping to balance moisture levels, enhance skin elasticity, improve pore appearance and scars, and boost overall skin firmness. There’s also a treatment called SculpSure, which uses PLLA injections to promote collagen production within the skin—making it a non-invasive treatment method. Since PLLA gradually breaks down in the body, it naturally stimulates collagen production over time. The effects of SculpSure aren’t immediate; they become evident over several months as you experience gradual improvement in natural fullness, reduction in fine lines, and enhanced skin elasticity. Recently, in addition to products like Macrogen, Juveline, and SculpSure, there have emerged treatment options using “LITUO” to manage dry skin and alleviate dryness issues. LITUO can fundamentally improve skin elasticity, density, fine lines, and pore condition, and even rebuild the skin structure, which is why users are highly satisfied with it. Lee Jeong-hyun, director of Jryn Hospital in Busan, says, “With the arrival of cold winter winds, many clients ask about the effectiveness of products like Juveline or SculpSure due to dry skin, deeper fine lines, and reduced skin elasticity. To maximize satisfaction from treatments, it’s crucial to first undergo a face consultation to accurately assess your skin condition and understand the differences between Juveline, Macrogen, SculpSure, and LITUO. Additionally, different treatment plans yield varying results, so beyond checking out price discounts for SculpSure or Juveline or reading user experiences with Macrogen and LITUO, it’s essential to fully understand the practitioner’s experience and expertise.” For more details, please visit the following link: >>>> View original article: https://mdtoday.co.kr/news/view/1065576709332356